A business plan to help the 'global South' in its fight against neglected diseases.

Although neglected tropical diseases (NTDs) threaten the health of those living in the developing world, innovation directed toward addressing NTDs is comparatively meager. Health biotechnology firms in rapidly growing economies in the global South are developing and selling vaccines, diagnostics, and therapeutics for these diseases to local markets. In this paper we identify a pipeline of sixty-two NTD products from seventy-eight "Southern" companies. We also propose creation of a Global Health Accelerator-a new nonprofit organization whose mission would be to support and help grow this Southern source of affordable innovation for NTDs.

[1]  Mary Moran,et al.  A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need , 2005, PLoS Medicine.

[2]  D. Wirth,et al.  Drugs for neglected diseases: a failure of the market and a public health failure? , 2001, Tropical medicine & international health : TM & IH.

[3]  Jaideep P. Sundaram,et al.  Health Innovation Networks to Help Developing Countries Address Neglected Diseases , 2005, Science.

[4]  J. Guzman,et al.  Neglected Disease Research and Development: How Much Are We Really Spending? , 2009, PLoS medicine.

[5]  B. Thylefors,et al.  Towards the elimination of onchocerciasis , 2006, Annals of tropical medicine and parasitology.

[6]  Peter A Singer,et al.  Small but tenacious: South Africa's health biotech sector , 2009, Nature Biotechnology.

[7]  India's health biotech sector at a crossroads , 2007, Nature Biotechnology.

[8]  P. Singer,et al.  The Indian and Chinese health biotechnology industries: potential champions of global health? , 2008, Health affairs.

[9]  Els Torreele,et al.  Drug development for neglected diseases: a deficient market and a public-health policy failure , 2002, The Lancet.

[10]  A. Daar,et al.  Brazilian health biotech—fostering crosstalk between public and private sectors , 2008, Nature Biotechnology.

[11]  D. Durrheim,et al.  Current Concepts Control of Neglected Tropical Diseases , 2007 .

[12]  E. Torreele,et al.  Global framework on essential health R&D , 2006, The Lancet.

[13]  A. Daar,et al.  Chinese health biotech and the billion-patient market , 2008, Nature Biotechnology.